Back to Journals » Patient Related Outcome Measures » Volume 5

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life

Total article views   HTML views PDF downloads Totals
23,978 Dovepress* 10,549+ 2,168 12,717
PubMed Central* 13,429 1,348 14,777
Totals 23,978 3,516 27,494
*Since 4 April 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar